Navigation Links
Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy

ts taking statins continue to have clinical events, and increasing HDL has been widely accepted as a potential major new approach in reducing the residual risk of a heart attack or stroke in high-risk patients taking statin drugs. The results obtained with the imaging techniques, including IVUS, clearly indicate that imaging trials can be an effective way to obtain and assess data which can be useful in determining the potential of new HDL therapies. Existing epidemiological data and pre-clinical animal studies continue to provide us with overwhelming evidence that higher levels of HDL, or increasing the functionality of existing HDL, will result in reduced cardiovascular disease. Twenty years after the introduction of statins, HDL therapy is clearly now the new frontier. The field is wide open to pursue innovative solutions focused on HDL therapy, and the unmet clinical need is clear."

In a recent study report in the March 26, 2007 issue of The New England Journal of Medicine, Dr. John J.P. Kastelein, Academic Medical Centre, University of Amsterdam, and member of the Lipid Sciences' Scientific Advisory Board noted, that even with the most aggressive treatment, (statin) drugs reduce the risk of a major coronary event by only 30%. This finding, combined with a projection that mortality from cardiovascular causes will increase worldwide by 90% by the year 2020, as compared with that in 1990, illustrates the need for new efficacious treatments for cardiovascular disease.

Furthermore, as an industry expert, Dr. Brewer was recently featured in a Medscape interview, "Raising High-Density Lipoprotein Cholesterol: What Are We Learning From the Torcetrapib Experience?" providing perspective on the current state of HDL Therapy and its future potential. The full text of the article will be available on our website: www.lipidsciences.com at the Lipid Sciences in the News heading.

Lipid Sciences'
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
2. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
4. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
5. Inspire Announces Presentations at Two European Scientific Conferences
6. Presentations at 2007 European Stroke Congress Highlights New Direction for Viprinex (ancrod)
7. IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at 2007 ASCO Annual Meeting
8. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
9. Pharmacyclics Announces Presentations and Published Abstracts on Xcytrin at The 2007 American Society of Clinical Oncology Annual Meeting
10. Schering-Plough Announces Hepatitis C Data Presentations at Digestive Disease Week (DDW) 2007 Annual Meeting
11. Lux Biosciences Investigational Therapy for Uveitis, LX211, is Subject of Two Presentations at Key Ophthalmology Meeting, ARVO 2007
Post Your Comments:
(Date:9/16/2014)... Tenn. , Sept. 16, 2014 A ... investigators has found the chemotherapy dose threshold below ... normal sperm production. The study appears in September 17 ... By clarifying which patients are at highest risk ... findings to eventually increase use of pre-treatment fertility preservation ...
(Date:9/16/2014)... -- Chindex International, Inc. ("Chindex" or the "Company") (Nasdaq: ... meeting of stockholders held today, the Company,s stockholders adopted ... and among the Company, Healthy Harmony Holdings, L.P. ("Parent"), ... an affiliate of TPG, Shanghai Fosun Pharmaceutical (Group) Co., ... CEO of the Company. The Merger Agreement ...
(Date:9/16/2014)... , Sept. 16, 2014 Research and Markets ... Vaccines Market 2014-2018" report to their offering. ... immunity of animals. Animal vaccines are generally prepared from weakened ... in their healthy state. Some of the animal vaccines are ... as protein subunits or toxic components. These ...
Breaking Medicine Technology:Improved risk identification will aid fertility preservation in young male cancer patients 2Improved risk identification will aid fertility preservation in young male cancer patients 3Improved risk identification will aid fertility preservation in young male cancer patients 4Chindex Stockholders Approve Merger 2Chindex Stockholders Approve Merger 3Global Animal Vaccines Market 2014-2018: Key Vendors are Bayer, Elanco, Merck, Novartis, Sanofi and Zoetis 2Global Animal Vaccines Market 2014-2018: Key Vendors are Bayer, Elanco, Merck, Novartis, Sanofi and Zoetis 3
... BioStorage Technologies, Inc., a worldwide provider of long- and ... logistics, will expand its European operations with the opening ... full-service biorepository in Frankfurt, Germany. , BioStorage Technologies, expanded ... plan to accommodate a rapidly growing list of customers ...
... Oct. 21 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHMD) ... bavituximab in combination with docetaxel in patients with advanced breast ... planned treatment cycles in the Phase II study showed that ... the trial achieved an objective tumor response according to RECIST ...
Cached Medicine Technology:BioStorage Technologies, Inc., Accelerates European Expansion with Opening of New German Facility 2Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer 2Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer 3Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer 4
(Date:9/16/2014)... Recently, BamboofloorChina.com, the popular online supplier of elegant ... strand woven bamboo floors to its product catalogue. ... for the new items; the current discount is up ... great shopping season. Therefore, BamboofloorChina.com spares no energy to ... All practical items offered by BamboofloorChina.com are in stock ...
(Date:9/16/2014)... Marybeth Cale, owner of Cale Communications , a public ... small village of Rhinebeck, New York, has announced the launch ... has expanded the business to incorporate a new scope of ... Those services will include group trainings and workshops on a ... clients all over the country. , Workshops address topics ...
(Date:9/16/2014)... 17, 2014 Operation Smile was founded “on ... of a facial deformity.” To spread their message and mission, ... 2014, at the Beverly Wilshire Hotel in Beverly Hills, California. ... worldwide whose lives have been forever transformed by the efforts ... involved with Operation Smile,” said Lynda Erkiletian, Executive Director of ...
(Date:9/16/2014)... On Friday, September 12, Jusuru International ... an accompanying mobile application, the grand-opening of their ... their sales force, and their sponsorship of the ... national convention, Rise to Enterprise 2014 (R2E14). , ... Regency Orange County was treated to a new ...
(Date:9/16/2014)... September 16, 2014 Pulmonary Hypertension Association Travels ... Education Forum for PH Patients and Families to Help Fight ... – the country’s leading pulmonary hypertension association that works to ... a disease of the lungs that affects the functioning of ... treatment, mean survivability is only 2.8 years. , What:, ...
Breaking Medicine News(10 mins):Health News:BamboofloorChina.com Announces Its Promotion For Strand Woven Bamboo Floors 2Health News:Mompreneur Marybeth Cale of Cale Communications Announces Launch Of Life Coaching And Workshop Business 2Health News:James & Paula Coburn Foundation to Host the 2014 Smile Gala, Presented by Operation Smile 2Health News:New Products Announced at Jusuru International’s R2E14 National Convention 2Health News:New Products Announced at Jusuru International’s R2E14 National Convention 3Health News:New Products Announced at Jusuru International’s R2E14 National Convention 4Health News:Pulmonary Hypertension Association Travels to San Diego for PHA On The Road to Help Fight Rare Lung Disease 2Health News:Pulmonary Hypertension Association Travels to San Diego for PHA On The Road to Help Fight Rare Lung Disease 3
... the House of Commons vote to impose a ban on smoking ... of researchers measured the air quality, using a portable monitor in ... smoking was permitted. The study revealed that the quality of air ... inhaled, would cause harm to the health. ,Dr Richard ...
... An outbreak of cholera was first reported in the Luanda ... nearly 652 cases of cholera// and 22 cholera related deaths ... the latest health report published by the World Health Organization, ... reported over the past 24 hours. 8 municipalities have been ...
... show that about one in 100 11-year-olds had taken a ... one in 10 of 15-year-olds// have taken hard drugs. There ... They take illegal drugs such as cocaine which has created ... The survey was carried out among England's 3.4 million secondary ...
... has developed a technique which uses plastidial transformation which ... from tobacco plants. HSA is an intravenous protein most ... ,It is mainly used to stabilize blood volume ... used for haemorrhages, burns, surgical operations or when the ...
... have joined forces to create an Internet-based training ... postgraduate degrees while continuing to work. ... early March, will create online courses for vets ... science-for-development network. ,African vets urgently need ...
... at the 5th European Breast Cancer Conference (EBCC-5) have called ... and advances made in the field. Doctors and patient groups ... to new drugs like Herceptin that could help prolong their ... in reconstructive surgery and radiation therapy are available to women ...
Cached Medicine News:Health News:Alternate ways to produce HAS from tobacco plants 2
... concave seats and standard-sized backrests with ... seats, backrests, armrests, and casters and ... for the following environments: industry, education, ... care and office. • With tubular ...
... ergonomic chairs with concave seats ... support • Select options like ... and glides. • BTT/1P chairs ... environments: industry, education, laboratory, clean ...
... ergonomic chairs with concave seats ... support • Select options like ... and glides. • BTT/1P chairs ... environments: industry, education, laboratory, clean ...
... chairs with concave seats and large ... options like seats, backrests, armrests, and ... BE Series for top performance in ... education, laboratory, clean room, static control, ...
Medicine Products: